Financial Results
Egyptian International Pharmaceuticals (EIPICO) (PHAR.CA) Reports Its Financial Results (Standalone) for The Period From 01/01/2026 to 31/03/2026
Published at 17 May 2026 at 10:46Egyptian International Pharmaceuticals (EIPICO)Related stock:Egyptian International Pharmaceuticals (EIPICO) stockAll Egyptian International Pharmaceuticals (EIPICO) disclosures
Disclosure summary
Company Name: Egyptian International Pharmaceuticals (EIPICO)
ISIN Code: EGS38081C013
Currency: Egyptian Pound
F/S (Standalone) Period: From 01/01/2026 to 31/03/2026
Net profit: 268,960,528
F/S (Standalone) Period: From 01/01/2025 to 31/03/2025
Net Comparative profit: 318,999,555
Audit Status: Reviewed
Source: Egyptian International Pharmaceuticals (EIPICO)
The BoD Report in Arabic (287 KB)
The BoD Report in English (160 KB)
ISIN Code: EGS38081C013
Currency: Egyptian Pound
F/S (Standalone) Period: From 01/01/2026 to 31/03/2026
Net profit: 268,960,528
F/S (Standalone) Period: From 01/01/2025 to 31/03/2025
Net Comparative profit: 318,999,555
Audit Status: Reviewed
Source: Egyptian International Pharmaceuticals (EIPICO)
The BoD Report in Arabic (287 KB)
The BoD Report in English (160 KB)